AVR-118

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameAVR-118
Drug Alias NameSubstance RReticuloseProduct RPeptide ROHR-118 +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Peptide nucleic acids
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)AnorexiaCachexia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesBrazil
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Viral Research Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Viral Research CorpOhr Pharmaceutical IncMcGill University +[4] 
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)AnorexiaCachexia +[5] 

Other Information

ATC CodeN/A
Related LinksDrugBank